Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06392347 · ClinicalTrials.gov registry record
Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging
A clinical trial, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- 15
- Enrollment target
NCT06392347: Clinical Trial study, sponsored by University of Pennsylvania.
NCT06392347 is a clinical trial that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06392347 has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to compare and evaluate a faster MR image that has been optimized to look at participants blood vessel walls.
Primary Outcome
The primary outcome of the study will be the raters study where qualitative imaging scores will be provided by experienced radiologists using a four-point scale.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2027-08 |
| Est. Completion | 2030-07 |
What is known before NCT06392347 opens enrollment
NCT06392347 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06392347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06392347 about?
NCT06392347 is a clinical study titled "Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging". The purpose of this study is to compare and evaluate a faster MR image that has been optimized to look at participants blood vessel walls.
What is the current status of trial NCT06392347?
This trial is currently not yet recruiting. The enrollment target is 15 participants. The study started on 2027-08. Estimated completion is 2030-07.
Who is sponsoring clinical trial NCT06392347?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia